APA (7th ed.) Citation

Cadranel, J., Liu, S. V., Duruisseaux, M., Branden, E., Goto, Y., Weinberg, B. A., . . . Renouf, D. J. (2021). Therapeutic potential of Afatinib in NRG1 fusion‐driven solid tumors: A case series. The oncologist, 26(1), . https://doi.org/10.1634/theoncologist.2020-0379

Chicago Style (17th ed.) Citation

Cadranel, Jacques, et al. "Therapeutic Potential of Afatinib in NRG1 Fusion‐driven Solid Tumors: A Case Series." The Oncologist 26, no. 1 (2021). https://doi.org/10.1634/theoncologist.2020-0379.

MLA (9th ed.) Citation

Cadranel, Jacques, et al. "Therapeutic Potential of Afatinib in NRG1 Fusion‐driven Solid Tumors: A Case Series." The Oncologist, vol. 26, no. 1, 2021, https://doi.org/10.1634/theoncologist.2020-0379.